Clinical Trials Logo
  1. Home
  2. Non-healing Wound
  3. NCT03049670

The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study — Klorsept  

Non-healing Wound Clinical Trial

Official title:
The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study

Clinical Trial Summary

Klorsept is a debridement solution of necrotic infected tissue promoting wound healing. The aim of this study is to elaborate the effectiveness and safety of this solution.

Clinical Trial Description

Klorsept is a debridement solution of necrotic infected tissue promoting wound healing. The aim of this study is to elaborate the effectiveness and safety of this solution.

This study will include 50 patients suffering from necrotic and infected wounds. Several parameters will be evaluated in order to provide the effectiveness and safety of this treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03049670
Study type Observational
Source Carmel Medical Center
Contact
Status Not yet recruiting
Phase N/A
Start date March 1, 2017
Completion date March 1, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03632031 - Treatment of Wounds Using Oasis® ECM
Completed NCT03230175 - Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) Phase 2
Completed NCT04483934 - Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts Phase 1/Phase 2
Terminated NCT04134143 - Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers Phase 1
Recruiting NCT04450693 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) Phase 3
Completed NCT06442865 - AMNIODERM+ Medical Device Clinical Study
Not yet recruiting NCT06327113 - Antibiotic Tumescent For Chronic Wounds Phase 2
Not yet recruiting NCT05766982 - Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP) N/A
Completed NCT05921292 - Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies Early Phase 1
Completed NCT04176120 - Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU) Phase 3
Completed NCT02657876 - ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers Phase 1
Not yet recruiting NCT06109844 - FORCEREPAIR - A Wound Exudate Investigation
Terminated NCT04240574 - Debritom - Micro Water Jet Technology and Wound Healing N/A
Completed NCT05154838 - Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
Not yet recruiting NCT03732365 - Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds Phase 2
Not yet recruiting NCT05251480 - Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People N/A
Completed NCT04344483 - Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh N/A
Recruiting NCT05739149 - A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers N/A
Completed NCT03863054 - An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
Recruiting NCT06028386 - Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers N/A